AN2 Therapeutics (ANTX) Selling, General & Administrative (2021 - 2026)
AN2 Therapeutics' Selling, General & Administrative was $2.89 million in Q2 2026, down 28.2% from $4.02 million a year earlier and down 24.2% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, AN2 Therapeutics' Selling, General & Administrative was $12.17 million through Jun 30, 2026, down 16.4% year-over-year; for FY2025, it came in at $13.34 million, down 5.2% from FY2024.
- Selling, General & Administrative shows a four-year compound annual growth rate of 30.0% (FY2021 to FY2025).
- In earlier years, Selling, General & Administrative was $14.07 million in FY2024 (-4.7%), $14.76 million in FY2023 (+15.8%), $12.75 million in FY2022 (+173.2%) and $4.67 million in FY2021.
- Quarterly Selling, General & Administrative has moved between $1.59 million (Q3 2021) and $4.05 million (Q1 2023) over five years.
- Compared with a year earlier, Selling, General & Administrative has declined for four straight quarters, with an average decline of 9.7% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2022 (growth of 411.2%); the worst was Q2 2026 (a decline of 28.2%).
- Per Business Quant data, ANTX's Selling, General & Administrative in the three quarters before Q2 2026 was $3.81 million (Q1 2026), $2.44 million (Q4 2025) and $3.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | AN2 Therapeutics | 164.30 Mn | -121.79 Mn | - | 2.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.95 Mn |
| Jun 30, 2026 | 2.89 Mn |
| Mar 31, 2026 | 3.81 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | 4.02 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.64 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 3.75 Mn |
| Jun 30, 2023 | 3.06 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 3.72 Mn |
| Sep 30, 2022 | 3.34 Mn |
| Jun 30, 2022 | 3.64 Mn |
| Mar 31, 2022 | 2.05 Mn |
| Dec 31, 2021 | 1.78 Mn |
API Access
AN2 Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();